Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Study of Intranasal Metoclopramide in Diabetic Gastroparesis
NCT02025725Phase 3Completed
- Sponsor
- Evoke Pharma, Inc.
- Start
- Mar 2014
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in diabetic gastroparesis comparing Metoclopramide Nasal Spray with Placebo Nasal Spray (2 arms). Primary endpoint: Gastroparesis Symptom Assessment at 4 weeks. Started Mar 2014; status: completed.
02
Drugs
metoclopramide
03
Conditions
diabetic gastroparesis
Beyond the preview
Go deeper on NCT02025725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02025725.